Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2013-04-30 Declaration of Voting R…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1295 characters) and explicitly announces the 'Total Voting Rights' as of April 30, 2013, referencing Article 26a of the WpHG. This type of announcement, which reports a specific metric related to shareholder voting power rather than the results of a vote or a full meeting agenda, fits best under the category dealing with voting rights announcements. While DVA (Declaration of Voting Results & Voting Rights Announcements) is a possibility, the content is a simple notification of the total number of rights, which is a specific type of regulatory disclosure. Given the options, DVA covers announcements related to voting rights. However, since this is a simple notification of the total number of shares/rights outstanding, and not the results of a specific vote (which DVA usually implies), it is a specific regulatory disclosure. Looking closely at the definitions, DVA is for 'Official results from shareholder votes at any general meeting'. This document is a 'Total Voting Rights Announcement'. This specific type of disclosure is often categorized under general regulatory filings (RNS) or sometimes under DVA if the system lumps all voting-related disclosures there. Since DVA is defined as 'Declaration of Voting Results & Voting Rights Announcements', and this is a 'Total Voting Rights Announcement', DVA is the most specific fit among the provided codes, even if it's not a 'result' of a vote. If DVA is strictly for results, RNS would be the fallback. Given the context of voting rights, DVA is chosen as the primary fit.
2013-04-30 English
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 05.06.2013 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung 2013' (Invitation to the Annual General Meeting 2013) and details the agenda ('Tagesordnung') for the meeting scheduled for June 5, 2013. The agenda items include presenting the 2012 annual financial statements, proposing dividend usage, voting on discharge for management/supervisory boards, appointing auditors, and crucially, proposing changes to authorized capital, which are typical items for an AGM. This clearly identifies the document as material related to an Annual General Meeting.
2013-04-26 German
DGAP-DD: STADA Arzneimittel AG deutsch
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and the German equivalent "Directors’-Dealings-Mitteilung". It details a transaction (Kauf/Buy) by a member of the management body (Geschäftsführendes Organ) named Hartmut Retzlaff, including the date, price, and number of shares. This directly corresponds to the definition of Director's Dealing reports.
2013-04-03 German
DGAP-DD: STADA Arzneimittel AG deutsch
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and explicitly mentions 'DGAP-DD: STADA Arzneimittel AG deutsch' and 'Directors’-Dealings-Mitteilung'. It details a transaction ('Geschäftsart: Verkauf') by a member of the management ('Funktion: Geschäftsführendes Organ') involving financial instruments. This content directly corresponds to the definition of Director's Dealing reports.
2013-04-03 German
Annual Financial Statements 2012
Annual Report Classification · 100% confidence The document is titled 'STADA Annual Report 2012' and contains comprehensive financial statements, a letter to shareholders, management reports, and auditor's reports for the full fiscal year. It is a complete annual report, not an announcement or a summary, and therefore fits the definition of a 10-K (Annual Report). FY 2012
2013-03-25 English
Annual Financial Statements 2012
Annual Report Classification · 100% confidence The document is titled 'STADA Annual Report 2012' and contains comprehensive financial statements, a letter to shareholders, management reports, and auditor's reports for the full fiscal year. It is a complete annual report, not an announcement or a summary, and therefore fits the definition of a 10-K (Annual Report). FY 2012
2013-03-25 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.